Photo of Lecia Sequist from X
Dec 11, 2024, 14:33
Lecia Sequist highlights the established importance of biomarker testing to tailor appropriate treatment
Coral Olazagasti shared on X:
“Look how far we’ve come
Lecia Sequist presents all the approved agents for NSCLC
This continues to highlight the established importance of biomarker testing to tailor appropriate treatment. “
Coral Olazagasti, MD is an assistant professor at the Sylvester Cancer Center, University of Miami at Miami. Being a Latina physician, she is personally invested in ethnic and racial disparities in the medical field. She earned her MD from the Universidad Central del Caribe, Puerto Rico.
More posts featuring Coral Olazagasti.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 07:13
Aug 24, 2025, 04:55
Aug 24, 2025, 01:32
Aug 23, 2025, 22:57
Aug 23, 2025, 22:35